Q32 Bio Inc.
QTTB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $78 | $26 | $44 | $108 |
| Short-Term Investments | $0 | $0 | $0 | $47 |
| Receivables | $1 | $1 | $1 | $0 |
| Inventory | $0 | $0 | $2 | $0 |
| Other Curr. Assets | $3 | $2 | $0 | $36 |
| Total Curr. Assets | $82 | $29 | $47 | $192 |
| Property Plant & Equip (Net) | $7 | $8 | $9 | $18 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $3 | $0 | $26 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $10 | -$20 | $0 |
| Total NC Assets | $10 | $18 | $15 | $20 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $92 | $47 | $62 | $212 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $1 | $2 |
| Short-Term Debt | $4 | $1 | $33 | $0 |
| Tax Payable | $0 | $0 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $15 | $3 |
| Other Curr. Liab. | $10 | $9 | $8 | $11 |
| Total Curr. Liab. | $16 | $14 | $58 | $17 |
| LT Debt | $15 | $49 | $12 | $24 |
| Deferred Rev, NC | $0 | $0 | $11 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $55 | $166 | $111 | $0 |
| Total NC Liab. | $70 | $216 | $135 | $25 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6 | $7 | $7 | $24 |
| Total Liabilities | $87 | $230 | $192 | $42 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$235 | -$187 | -$133 | -$424 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $240 | $4 | $1,323 | $594 |
| Total Equity | $6 | -$183 | -$131 | $170 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $92 | $47 | $62 | $212 |
| Net Debt | -$59 | $25 | $1 | -$84 |